Sept. 18 FDA Public Workshop Highlights Progress in Implementing Agency's Predictive Toxicology Roadmap

Sept. 18, 2019 FDA Public Workshop

Implementing FDA’s Predictive Toxicology Roadmap:

An Update of FDA Activities

FDA's Predictive Toxicology Roadmap

Wednesday, Sept. 18, 2019

8 a.m. – 4 p.m.

FDA Headquarters, White Oak Campus

Building 31, Great Room 1503A

Register Here

Agenda

Join FDA on Wednesday, Sept. 18 at its public workshop, showcasing the agency’s progress in supporting and implementing the FDA Predictive Toxicology Roadmap. 

At its Sept. 12, 2018 Public Hearing, FDA sought stakeholder input on how best to foster the development and evaluation of emerging toxicological methods and new technologies and incorporate them into regulatory review.

Toxicology testing plays a critical role in ensuring the safety of FDA-regulated products.  Breakthrough methods like organs-on-a-chip and mathematical modeling are being developed for toxicity testing that are generating unique opportunities to improve FDA’s ability to quickly and more accurately predict potential toxicities and reduce associated risks.

FDA expects these advances will help us move products to market faster and prevent products with increased toxicological risk from reaching the market. In many cases, these technologies are, in fact, reducing the need for animal testing – furthering FDA’s long-sought goal of refining, reducing, and replacing testing on animals.